232 related articles for article (PubMed ID: 35936781)
21. A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma.
Wang C; Chen S; Li S; Mi H
Front Genet; 2022; 13():708003. PubMed ID: 35251120
[TBL] [Abstract][Full Text] [Related]
22. Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma.
Xu Q; Chen S; Hu Y; Huang W
Cancer Cell Int; 2021 Oct; 21(1):582. PubMed ID: 34717651
[TBL] [Abstract][Full Text] [Related]
23. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment.
Chen J; Lv B; Zhan Y; Zhu K; Zhang R; Chen B; Jin Y; Li Y; Zheng J; Lin C
Front Oncol; 2022; 12():724261. PubMed ID: 35237505
[TBL] [Abstract][Full Text] [Related]
25. Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma.
Lv Y; Jin P; Chen Z; Zhang P
Am J Transl Res; 2020; 12(11):7510-7527. PubMed ID: 33312386
[TBL] [Abstract][Full Text] [Related]
26. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
27. Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA.
He Z; Gu J; Luan T; Li H; Li C; Chen Z; Luo E; Wang J; Huang Y; Ding M
Front Immunol; 2022; 13():973974. PubMed ID: 36211333
[TBL] [Abstract][Full Text] [Related]
28. Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy.
Yang D; Zhao F; Su Y; Zhou Y; Shen J; Zhao K; Ding Y
Front Mol Biosci; 2023; 10():1184708. PubMed ID: 37469705
[No Abstract] [Full Text] [Related]
29. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
30. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
Front Genet; 2021; 12():551605. PubMed ID: 33732281
[No Abstract] [Full Text] [Related]
31. A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
Zhang M; Zhang X; Yu M; Zhang W; Zhang D; Zeng S; Wang X; Hu X
Front Oncol; 2021; 11():698856. PubMed ID: 34386423
[TBL] [Abstract][Full Text] [Related]
32. Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma.
Gu Y; Zhuo H
Aging Male; 2023 Dec; 26(1):2233609. PubMed ID: 37428096
[TBL] [Abstract][Full Text] [Related]
33. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
34. A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma.
Li X; Huang J; Chen J; Zhan Y; Zhang R; Lu E; Li C; Zhang Y; Wang Y; Li Y; Zheng J; Geng W
Front Oncol; 2021; 11():726486. PubMed ID: 34966666
[TBL] [Abstract][Full Text] [Related]
35. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
[TBL] [Abstract][Full Text] [Related]
36. A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer.
Xie S; He J; Feng B; Rao D; Wang S; He Y
Heliyon; 2023 May; 9(5):e15897. PubMed ID: 37215925
[TBL] [Abstract][Full Text] [Related]
37. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
38. In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer.
Wang L; Wang Y; Bi J
Funct Integr Genomics; 2022 Oct; 22(5):797-811. PubMed ID: 35896848
[TBL] [Abstract][Full Text] [Related]
39. Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer.
Dong B; Liang J; Li D; Song W; Song J; Zhu M; Zhao S; Ma Y; Yang T
Front Mol Biosci; 2021; 8():688298. PubMed ID: 34368227
[No Abstract] [Full Text] [Related]
40. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
